David Dahlgren

Consultant, Drug Development

David Dahlgren is Consultant, Drug Development, at Cytel and Associate Professor (Docent) of Translational Drug Discovery and Development at Uppsala University. He is an expert in drug development and pharmacokinetics, including in vitro, in vivo, and in silico biopharmaceutics research and regulatory consultant work.

Related Articles

How to Save Time and Limit Costs toward First-in-Human Clinical Trials
Blog
January 22, 2024
How to Save Time and Limit Costs toward First-in-Human Clinical Trials
Read More